Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency

Journal of Pediatric Endocrinology and Metabolism

Volumn 11, Issue SUPPL. 3, 1998, Pages 845-849

  Cavallo, L ^a,g   Gurrado, R ^a   Zecchino, C ^a   Manolo, F ^b   De Sanctis, V ^b,f   Cisternino, M ^c   Caruso Nicoletti, M ^d   Galati, M ^e  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF CATANIA   (Italy)

^f Servizio di Microcitemia ed Emopatie Infantili   (Italy)

^g POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HUMAN GROWTH HORMONE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ADOLESCENT; ADULT; BLOOD TRANSFUSION; BODY HEIGHT; BONE AGE; CHELATION THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; FEMALE; GROWTH RATE; GROWTH RETARDATION; HUMAN; MALE; SCHOOL CHILD; SUBCUTANEOUS DRUG ADMINISTRATION; THALASSEMIA MAJOR;

ADOLESCENT; AGE DETERMINATION BY SKELETON; BETA-THALASSEMIA; BLOOD TRANSFUSION; BODY HEIGHT; CHILD; DEFEROXAMINE; FEMALE; FERRITINS; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; IRON CHELATING AGENTS; MALE;

EID: 0032424337     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Cavallo L, De Mattia D, Giobbe T, Liuzzi S, Acquafredda A, Sabato V, Schettini F. Growth in homozygous β-thalasseinia patients. In: Cavallo L, Job JC, New MI, eds. Growth Disorders: The State of the Art. Serono Symposia No. 81. Rome: Raven Press, 1991; 47-54.
2. Garcia-Mayor RVG, Andrade Olivie A, Fernandez Catalina P, Castro M, Rego Iraeta A, Reparaz A. Linear growth in thalassemic children treated with intensive chelation therapy. A longitudinal study. Horm Res 1993; 40: 189-93.
3. Rodda CP, Reid ED, Johnson S, Doery J, Matthews R, Bowden DK. Short stature in- homozygous β-thalassemia is due to disproportionate truncal shortening. Clin Endocrinol 1995; 42: 587-592.
4. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976; 51: 170-179.
5. Perignon F, Brauner R, Souberbielle JC, de Montalembert M, Girot R. Croissance et fonction endocrine dans la thalassemie majeure. Arch Franç Pediatr 1993; 50: 657-663.
6. De Sanctis V, Vullo C, Bagni B, Orzincolo C, Resca A, Nannetti C, Atti G, Di Palma A. Talassemia, chelazione ed accrescimento staturale. In: Tatò L, Boghen M, Piemonte G, eds. Le Indicazioni Non Convenzionali dell'ormone Biosintetico della Crescita. Padova: San Marco Editrice, 1990; 78-86.
7. Kuo B, Zaino E, Roginsky MS. Endocrine function in thalassemia major. J Clin Endocrinol Metab 1968; 28: 805-808.
8. Canale VC, Steinherz P, New MI, Erlandson M. Endocrine function in thalassemia major. Ann NY Acad Sci 1974; 232: 333-345.
9. Costin G, Kogut MD, Hyman CB, Ortega JA. Endocrine abnormalities in thalassemia major. Am J Dis Child 1979; 133: 479-502.
10. Saenger P, Schwartz E, Markenson AL, Graziano JH, Levine LS, New MI, Hilgartner MW. Depressed serum somatomedin activity in β-thalassemia. J Pediatr 1980; 96: 214-218.